Advancing Cancer Immunotherapy: A Focus on Analytical Methods in Drug Development

Yesh Muralidharan is a Molecular Biology Build Fellow at Dream Venture Labs, where he works with students leading projects in Molecular Biology. Yesh is a Research Associate II at CRISPR Therapeutics, where he focuses on developing analytical methods using Flow Cytometry and Cell culture to help characterize drug product attributes like potency, efficacy, and safety. Yesh has 3 years of experience in Biotechnology. Before his time at CRISPR Therapeutics, he worked as research assistant at Johns Hopkins University where his research was primarily centered on cell line development and improved efficiency of cell line product yield. He also worked on helping support studies involved in understanding antibody responses in patients with different COVID-19 variants. He holds a master’s in Biotechnology from Johns Hopkins University. A fun fact about Yesh is that he likes to travel, cook, and learn new hobbies. His most recent list of hobbies include crocheting, rock climbing, and getting back to reading books again. He has a sweet tooth and is always looking for new baking recipes.